Teijin ( (TINLF) ) has released its Q4 earnings. Here is a breakdown of the information Teijin presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Teijin Limited is a diversified Japanese company operating primarily in the materials, fibers, and healthcare sectors, known for its innovative solutions in high-performance materials and healthcare products. In its latest earnings report for the fiscal year ending March 31, 2025, Teijin reported a revenue increase of 4.7% to 1,005.5 billion yen, with a significant rise in adjusted operating income by 25.7% to 27.6 billion yen, despite an operating loss of 71.8 billion yen due to impairment losses in its North American composites business. The company’s profit attributable to owners was 28.3 billion yen, a notable recovery from a loss in the previous year. Key performance metrics highlighted include a robust performance in the Fibers & Products Converting Business, with a revenue increase of 9.4%, and a challenging year for the Healthcare Business due to drug price revisions. Looking ahead, Teijin’s management plans to focus on financial soundness and strategic growth investments, forecasting a revenue of 860 billion yen and a profit of 12 billion yen for the next fiscal year.